Kabul begins freeing Taliban

Newly freed Taliban prisoners walk at Pul-e-Charkhi prison, in Kabul, Afghanistan August 13, 2020. Picture taken August 13, 2020. (REUTERS)
Short Url
Updated 15 August 2020

Kabul begins freeing Taliban

  • Release of final 400 inmates was approved by traditional Afghan grand assembly

KABUL: After months of delay, Afghanistan’s government has started releasing the last 400 Taliban inmates in its custody, clearing the way for long-awaited peace talks, officials confirmed on Friday.

Eighty of the 400 were set free on Thursday and, according to the government, more will be freed in the coming days. The release was a condition to begin intra-Afghan negotiations to end 19 years of conflict in the war-torn country. The talks, already delayed twice, are expected to take place in Qatar once the release process is complete.
“The release was to speed up efforts for direct talks and a lasting, nationwide cease-fire,” the Afghan National Security Council said in a statement accompanied by video footage showing former Taliban inmates calling on insurgent leaders and the government to engage in peace talks.
The prisoner release follows an agreement signed by the US and the Taliban in Qatar in February that stipulated the exchange of prisoners between President Ashraf Ghani’s government and the militants, who have gained ground in recent years.
The process, involving 5,000 Taliban detainees held by Kabul and 1,000 security forces imprisoned by the militants, was slated to begin in early March and should have been followed by an intra-Afghan dialogue.
Ghani, initially resistant to the idea of freeing the Taliban inmates, began to release them under US pressure. Some 4,600 Taliban inmates were freed over the few past months, but Ghani refused to free the remaining 400, arguing they were behind major deadly attacks and that setting them free was outside his authority.
Faced by mounting pressure, after Eid Al-Adha holidays two weeks ago, the president vowed to summon a traditional grand assembly, the Loya Jirga, to help him decide if the remaining Taliban inmates should be freed or not.


Footage showing men in uniforms mutilating the bodies of purported Taliban members went viral on social media this week, raising concerns that violence between security forces and the militants may impede the peace process despite the prisoner release.

Last week, the assembly approved the release, which is now underway and expected to be followed by the peace talks, in accordance with the US-Taliban deal.
The process, however, coincides with a spike in violence in the country and mutual accusations of an increase in assaults by the Taliban and Afghan government forces.
On Thursday, the Defense Ministry said it was probing a video circulating on social media showing men in army uniforms mutilating the bodies of purported Taliban fighters.
The UN requested that the incident be investigated. It remains unclear when and where it took place.
The Taliban, in a statement, said the bodies of their fighters were mutilated in the Arghandab district of the Zabul province.
Concerns are rising that similar acts of violence will further delay the peace process.
“Let us hope that this video does not become part of revenge-taking between the two sides and affect the process of peace. It is really unfortunate,” analyst Shafiq Haqpal told Arab News.
“As the violence continues, we see more brutal and shocking tactics from the sides and examples of revenge-taking, and that is very worrying and impacts any trust in a peace process,” Shaharzad Akbar, the chief of Afghanistan’s Independent Human Rights Commission, said in a Twitter post on Thursday.
“It is on the leadership of the two sides to have clear messages to their fighters to avoid war crimes and actions that further the instinct for revenge that will make the reconciliation that should come out of a peace process difficult,” she added.


Arthritis drug trialled as potential treatment for COVID-19

Updated 56 min 49 sec ago

Arthritis drug trialled as potential treatment for COVID-19

  • Dr. Andy Martin: We are conducting this study to see whether otilimab could potentially ease the effect of COVID- 19 on the lungs
  • Dr. Tim Felton: The primary end point of this study is that participants are alive and free of lung failure after 28 days — so this research is potentially life-saving

LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19.

The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foundation Trust (MFT).

The OSCAR study (Otilimab in Severe COVID-19 Related Disease) is sponsored and funded by the pharmaceutical company GlaxoSmithKline.

The study at the MRI is being led by Dr. Andy Martin, an Intensive Care and Anaesthesia Consultant.

Dr. Martin said: “The patients eligible to take part in this study are those experiencing very severe lung difficulties due to COVID-19 infection and are receiving oxygen or ventilator support.

“We are conducting this study to see whether otilimab — which is under investigation as a potential treatment for rheumatoid arthritis — could also potentially ease the effect of coronavirus on the lungs, dampening the impact of the virus on the immune system.

Christopher Corsico, Senior Vice President Development, GSK said: “We are continuing to work hard to find solutions to address the pandemic, including exploring potential treatment options for COVID-19 patients.

“We know that some COVID-19 patients experience an overreaction of their immune system — sometimes referred to as cytokine storm — which can lead to hospitalization or death. We believe that otilimab might be able to help counter or calm this process.

Dr. Tim Felton, Honorary Consultant, Senior Lecturer at The University of Manchester and Clinical Lead for all MFT COVID-19-related research studies, leads OSCAR at Wythenshawe Hospital, which is also part of MFT.

Dr. Felton said: “The primary end point of this study is that participants are alive and free of lung failure after 28 days — so this research is potentially life-saving.

“I’d like to thank our first OSCAR participant — as well as the thousands of others who have taken part in coronavirus studies at MFT to date — as every participant who takes part in our research is contributing to the coordinated effort to enhance understanding of this global pandemic.”